DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,444,403 | -2.9% | 465,314 | -6.0% | 1.66% | -6.1% |
| Q2 2023 | $118,836,000 | -25.3% | 495,150 | -21.5% | 1.77% | -32.5% |
| Q1 2023 | $159,064,460 | -7.9% | 631,108 | -3.0% | 2.62% | -22.9% |
| Q4 2022 | $172,735,336 | +3.0% | 650,800 | +0.3% | 3.40% | -3.3% |
| Q3 2022 | $167,663,000 | +20.3% | 649,128 | +18.1% | 3.52% | -16.0% |
| Q2 2022 | $139,398,000 | -11.6% | 549,851 | +2.3% | 4.18% | +12.3% |
| Q1 2022 | $157,704,000 | -12.4% | 537,634 | -1.7% | 3.73% | +12.6% |
| Q4 2021 | $179,939,000 | +7.5% | 546,910 | -0.5% | 3.31% | +19.9% |
| Q3 2021 | $167,343,000 | +28.2% | 549,674 | +13.0% | 2.76% | +31.4% |
| Q2 2021 | $130,552,000 | +60.7% | 486,480 | +34.8% | 2.10% | +42.9% |
| Q1 2021 | $81,221,000 | -9.2% | 360,855 | -10.4% | 1.47% | +4.3% |
| Q4 2020 | $89,456,000 | +23.0% | 402,700 | +19.2% | 1.41% | +19.5% |
| Q3 2020 | $72,723,000 | +161.3% | 337,730 | +114.5% | 1.18% | +115.3% |
| Q2 2020 | $27,836,000 | – | 157,417 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |